Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,250.00    50.00 (4.17%)
Bid:
1,190.00
Ask:
1,250.00
Spread: 60.00 (5.042%)
Market Cap: £834.51m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Trading Update

23 Jul 2013 08:09

RNS Number : 9168J
CVS Group plc
23 July 2013
 

 

23 July 2013

 

CVS Group plc (the "Group")

 

Trading Update

 

The Board is pleased to announce that the results for the year ended 30 June 2013 will be in line with market expectations and will be released on Tuesday 24 September 2013.

 

Total like-for-like Group turnover for the year showed growth of 3.4%. This growth was achieved despite sales being moderately impacted by snow during January (0.2% impact) and there being one fewer trading days in the second half of 2013 compared to 2012 (0.3% impact).

 

Good organic growth has been achieved in the core veterinary practices throughout the year. The period has seen growth of over 70% in the membership of loyalty schemes which now exceed 111,900 pets compared to 65,500 at this time last year. At current run rates loyalty schemes are contributing over 9% of the total revenue from practices.

 

It is pleasing to report that there has been significant growth in the e-commerce operations. Animed Direct is currently generating some £6.7 million of annualised revenue, compared with £3.5 million at 30 June 2012 and continues to show significant growth opportunities. In addition, five on-line practice shops were opened during the year.

 

Internally funded acquisition activity has continued to play an important part in the Group's strategy. In addition to the three practices and the pet crematorium acquired in the first half of the year, four practices, Cranmore (two sites in Chester), Archway (Petersfield), Alver (three sites in and around Gosport) and Filham Park (Ivy Bridge, Devon) were acquired during the second half. These four acquisitions extend the Group's practice division's operations and the sites are an excellent geographic fit with the Group's existing surgeries. All of the acquisitions have been successfully integrated into the Group. Subsequent to the year end on 15 July 2013, Crescent (Melton Mowbray) was acquired. Based on the last financial year prior to acquisition the aggregate turnover derived from these five additional practices amounted to £8.3 million.

 

As well as small animal services, the Filham Park and Crescent practices both include some equine activities, extending our offering in this area. The Cranmore acquisition includes a referrals centre and on 1 July 2013 Professor John Innes joined us as a Referrals Director to run and expand our referrals business. John has been a leading figure in the academic and animal orthopaedic worlds for many years; most recently he has been closely involved in developing clinical services at the University of Liverpool. Not only will John bring world class experience in orthopaedics to the Group, but he will also bring experience and expertise in the development of referral services.

 

In total the Group now operates 248 veterinary practices across the UK, an on-line dispensary and 11 on-line practice shops, 5 diagnostic laboratories and 2 pet crematoria. CVS continues to be the UK's largest operator in a highly fragmented market.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer 020 7496 3000

Aubrey Powell

Graeme Summers

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGZNNFKGFZG
Date   Source Headline
27th Sep 20117:00 amRNSPreliminary Results
22nd Sep 20114:01 pmRNSHolding(s) in Company
25th Jul 20117:00 amRNSTrading update and Acquisitions
18th Jul 20117:00 amRNSLTIP Award
24th May 201111:37 amRNSHolding(s) in Company
16th May 201110:17 amRNSHolding(s) in Company
11th May 20113:57 pmRNSHolding(s) in Company
11th May 20112:41 pmRNSHolding(s) in Company
11th May 20112:01 pmRNSHolding(s) in Company
10th May 20117:00 amRNSHolding(s) in Company
4th May 201111:24 amRNSHolding(s) in Company
19th Apr 201111:45 amRNSHolding(s) in Company
6th Apr 20113:34 pmRNSHolding(s) in Company
18th Mar 20114:23 pmRNSHolding(s) in Company
17th Mar 20117:00 amRNSInterim results
7th Feb 20117:00 amRNSNotice of Results
31st Dec 20107:00 amRNSTotal Voting Rights
22nd Dec 201010:46 amRNSPosting of Annual Report
21st Dec 20104:30 pmRNSHolding(s) in Company
17th Dec 20104:40 pmRNSSecond Price Monitoring Extn
17th Dec 20104:35 pmRNSPrice Monitoring Extension
16th Dec 201012:05 pmRNSDirector/PDMR Shareholding
10th Dec 201011:13 amRNSExercise of Share Options under LTIP
10th Dec 20107:00 amRNSDirector Resignation
9th Dec 20101:58 pmRNSResult of AGM
16th Nov 20107:00 amRNSAcquisition
14th Oct 201010:50 amRNSHolding(s) in Company
7th Oct 20101:59 pmRNSLTIP Award
6th Oct 201010:34 amRNSHolding(s) in Company
5th Oct 201011:42 amRNSHolding(s) in Company
5th Oct 20107:00 amRNSPreliminary Results
27th Aug 20104:06 pmRNSHolding(s) in Company
13th Aug 20104:17 pmRNSHolding(s) in Company
30th Jul 201010:23 amRNSNotification of Preliminary Results
26th Jul 20103:19 pmRNSHolding(s) in Company
2nd Jul 20107:00 amRNSDirector/PDMR Shareholding
29th Jun 20107:00 amRNSTrading Update & Acquisitions
25th Jun 201011:33 amRNSHolding(s) in Company
21st Jun 20109:39 amRNSHolding(s) in Company
24th May 201010:36 amRNSHolding(s) in Company
19th May 201011:43 amRNSHolding(s) in Company
19th May 20107:00 amRNSAcquisition & Trading Update
21st Apr 201012:11 pmRNSHolding(s) in Company
31st Mar 201012:43 pmRNSTotal Voting Rights
23rd Mar 20107:00 amRNSAcquisition of veterinary group
16th Mar 20107:00 amRNSAcquisition
15th Mar 20104:14 pmRNSHolding(s) in Company
10th Mar 201011:10 amRNSResult of GM
9th Mar 201010:32 amRNSHolding(s) in Company
19th Feb 20104:21 pmRNSAnalyst Conference Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.